Cboe UK CHF
PolyPeptide Group AG (PPGNZ.XC)
20.33
-1.02
(-4.80%)
At close: June 13 at 4:18:30 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
89,399
89,399
36,485
5,460
57,352
Investing Cash Flow
-91,018
-91,018
-59,512
-78,435
-80,845
Financing Cash Flow
-25,323
-25,323
84,547
-26,869
130,928
End Cash Position
68,277
68,277
95,706
37,528
136,303
Capital Expenditure
-86,968
-86,968
-56,733
-78,764
-77,708
Issuance of Capital Stock
0
--
--
0
182,141
Issuance of Debt
0
0
144,259
0
25,000
Repayment of Debt
-20,000
-20,000
-55,172
0
-50,000
Repurchase of Capital Stock
-11,962
--
0
-13,933
-5,464
Free Cash Flow
2,431
2,431
-20,248
-73,304
-20,356
12/31/2021 - 6/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade